Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ENDO PHARMACEUTICALS HLDGS I Financial Overview

  • Income Statement: ENDP
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 1.26 B 1.09 B 174.93 M 13.88%
    Gross Profit 993.30 M 868.24 M 125.06 M 12.59%
    Net Income Before Extra Items/Preferred Div 261.74 M 227.44 M 34.30 M 13.10%
    Operating Income 395.03 M 318.12 M 76.91 M 19.47%
    View Full Report

  • Cash Flow: ENDP
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -110.07 M -28.97 M -81.09 M 73.68%
    Net Cash Flow - Investing -178.83 M 614.53 M -793.36 M 443.63%
    Net Cash Flow/Operating Activities 356.60 M 365.74 M -9.14 M -2.56%
    View Full Report

  • Balance Sheet: ENDP

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 1.91 B 1.70 B 210.31 M 11.02%
    Total Liabilities 781.00 M 406.14 M 374.86 M 48.00%
    Shareholders Equity 1.13 B 1.29 B -164.56 M -14.59%
    View Full Report

  • Key Ratios / Statistics: ENDP

    • Valuation

      Price/Earnings (TTM) 12.21
      Price/Sales (TTM) 2.54
      Price/Book (MRQ) 1.97
      Price/Cash Flow (TTM) 9.50

    • Profitability

      Gross Margin 78.80
      Operating Margin 31.34
      Profit Margin 20.76

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 2.67
      Current Ratio (MRQ) 1.93
      Long Term Debt-to-Equity (MRQ) 23.67

    • Management Effectiveness

      Return on Equity (TTM) 19.50
      Return on Assets (TTM) 9.90
      Return on Investments (TTM) 19.13
    View All Key Ratios